Business
0
AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio - AbbVie News Center
Proposed acquisition adds a diverse pipeline of assets focused on elevating the standard of care for patients with dermatologic, respiratory and other related inflammatory and immunological...
Comments